Aimee DeGaetano

Aimee DeGaetano is a global medical strategy expert with a focus on real-world evidence (RWE) and medical technology (MedTech) like artificial intelligence, transforming healthcare through evidence-based medicine and digital health solutions.

She excels in building clinical evidence, conducting clinical research, and collaborating with key opinion leaders (KOLs), integrated delivery networks (IDNs), and data registries to enhance business outcomes and medical innovation.

Aimee's expertise spans areas such as population health, diversity, equity, and inclusion (DEI), medical education, clinical trials, health economics and outcomes research (HEOR), and managing medical science liaisons (MSLs).

Her career highlights include driving clinical strategy across various disease platforms like Neurovascular, Oncology, Cardiac, and Emergency Medicine, from product lifecycle management to FDA approval and beyond.

Aimee has a strong academic background, holding degrees in health science, public health, digital health, artificial intelligence in medicine, clinical nutrition, and international business from prestigious institutions like Harvard Business School and the University of Illinois Urbana-Champaign School of Medicine.

She has held key leadership positions in organizations such as Viz.ai, RapidAI, and Medtronic, overseeing medical affairs, KOL strategy, and clinical business development, showcasing her extensive experience in the healthcare industry.

Aimee has a proven track record of initiating abstracts at conferences, publishing in high-impact journals, and driving AI data collection and clinical data protocols to advance evidence-based medicine and AI integration in healthcare.

Her expertise also includes clinical competitive intelligence, real-world evidence (RWE) analysis, clinical gap assessments, and maintaining clinical thought leadership in rapidly evolving healthcare landscapes.